Your browser doesn't support javascript.
loading
Dose escalation prophylactic donor lymphocyte infusion after T-cell depleted matched related donor allogeneic hematopoietic cell transplantation is feasible and results in higher donor chimerism, faster immune re-constitution, and prolonged progression-free survival.
Kothari, Shawn; Artz, Andrew S; Lee, Sang Mee; Fulton, Noreen; Park, Jae-Hyun; Stock, Wendy; Larson, Richard A; Odenike, Olatoyosi; Kline, Justin; LaBelle, James; Kosuri, Satyajit; Riedell, Peter; Nakamura, Yusuke; Bishop, Michael R; Liu, Hongtao.
Afiliação
  • Kothari S; Section of Hematology/Oncology, Department of Medicine and Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA.
  • Artz AS; Section of Hematology/Oncology, Department of Medicine and Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA.
  • Lee SM; Department of Public Health Sciences, The University of Chicago, Chicago, IL, USA.
  • Fulton N; Section of Hematology/Oncology, Department of Medicine and Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA.
  • Park JH; Section of Hematology/Oncology, Department of Medicine and Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA.
  • Stock W; Section of Hematology/Oncology, Department of Medicine and Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA.
  • Larson RA; Section of Hematology/Oncology, Department of Medicine and Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA.
  • Odenike O; Section of Hematology/Oncology, Department of Medicine and Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA.
  • Kline J; Section of Hematology/Oncology, Department of Medicine and Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA.
  • LaBelle J; Department of Pediatrics, University of Chicago Medical Center, Chicago, IL, USA.
  • Kosuri S; Section of Hematology/Oncology, Department of Medicine and Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA.
  • Riedell P; Section of Hematology/Oncology, Department of Medicine and Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA.
  • Nakamura Y; Section of Hematology/Oncology, Department of Medicine and Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA.
  • Bishop MR; Section of Hematology/Oncology, Department of Medicine and Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA.
  • Liu H; Section of Hematology/Oncology, Department of Medicine and Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA. hliu2@medicine.bsd.uchicago.edu.
Bone Marrow Transplant ; 55(6): 1161-1168, 2020 06.
Article em En | MEDLINE | ID: mdl-31992847
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article